Journal of Allergy and Clinical Immunology: In Practice
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Evening ingestion as a potential reaction cofactor during peanut oral immunotherapy in children.
S2213-2198(23)00237-4.
2023
-
Varying Approaches to Management of IgE-Mediated Food Allergy in Children Around the World.
S2213-2198(23)00175-7.
2023
-
Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes.
S2213-2198(23)00178-2.
2023
-
A case series of dual biologics therapy for severe asthma.
11:335-340.e2.
2023
-
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction.
S2213-2198(23)00077-6.
2023
-
Are There Hidden Dangers Associated With Milk and Egg Dietary Advancement Therapy?.
S2213-2198(22)01328-9.
2022
-
Boxed Warnings and Off-Label Use of Allergy Medications: Risks, Benefits, and Shared Decision Making.
10:3057-3063.
2022
-
Diphenhydramine: Time to Move on?.
10:3124-3130.
2022
-
Educational resources received by families after successful baked egg/baked milk oral food challenge: An international survey.
10:3328-3332.e2.
2022
-
Impact of Reaction Setting on the Management, Severity, and Outcome of Pediatric Food-Induced Anaphylaxis: A Cross-Sectional Study.
10:3163-3171.
2022
-
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study.
10:3008-3017.e4.
2022
-
Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.
S2213-2198(22)01135-7.
2022
-
Trustworthy Patient-Centered Guidelines: Insights From Atopic Dermatitis and a Proposal for the Future.
10:2875-2877.
2022
-
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.
10:2657-2666.e8.
2022
-
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
10:2695-2709.
2022
-
Peanut Oral Immunotherapy With or Without H1 and H2 Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial.
10:2386-2394.
2022
-
Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose.
10:1462-1467.
2022
-
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air.
10:343-345.e2.
2022
-
International Peanut Allergy Prevention, 6 Years After the Learning Early About Peanut Study.
10:71-77.
2022
-
Translating Evidence to Optimize Patient Care Using GRADE.
9:4221-4230.
2021
-
Antibody Deficiency, Chronic Lung Disease, and Comorbid Conditions: A Case-Based Approach.
9:3899-3908.
2021
-
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process.
9:3997-4004.
2021
-
Reply to “As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function”.
9:4179-4180.
2021
-
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
9:3546-3567.
2021
-
Management of Eosinophilic Esophagitis During Oral Immunotherapy.
9:3282-3287.
2021
-
Web-based Infant Food Introduction (WIFI): Feasibility and satisfaction of virtual allergist-supervised food introduction.
9:3521-3523.e1.
2021
-
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.
9:2556-2561.
2021
-
The hidden allergen: Triton X-100, a derivative of polyethylene glycol.
9:2941-2941.
2021
-
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis.
9:2321-2333.
2021
-
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both.
9:2151-2157.
2021
-
Peanut allergen reaction thresholds during controlled food challenges in 2 Canadian randomized studies (Canada-ARM1 and PISCES).
9:2524-2526.e2.
2021
-
Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”.
9:2537-2539.
2021
-
A High Proportion of Canadian Allergists Offer Oral Immunotherapy but Barriers Remain.
9:1902-1908.
2021
-
An Approach to the Office-Based Practice of Food Oral Immunotherapy.
9:1826-1838.e8.
2021
-
Prenatal egg consumption and infant sensitization and allergy to egg, peanut, and cow's milk in the CHILD Cohort.
9:2109-2112.e2.
2021
-
Treatment Effect of the Tree Pollen SLIT-Tablet on Allergic Rhinoconjunctivitis During Oak Pollen Season.
9:1871-1878.
2021
-
A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough.
9:1640-1647.
2021
-
Sesame allergy a time burden for families of children with multiple food allergies.
9:1753-1755.e1.
2021
-
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World.
9:1438-1441.
2021
-
Fruit-Induced Anaphylaxis: Clinical Presentation and Management.
9:2825-2830.e2.
2021
-
Practical Challenges and Considerations for Early Introduction of Potential Food Allergens for Prevention of Food Allergy.
9:44-56.e1.
2021
-
Weighing peanut candies used for oral immunotherapy mitigates variable peanut protein dose.
9:521-523.e1.
2021
-
Increasing Awareness of the Low Risk of Severe Reaction at Infant Peanut Introduction: Implications During COVID-19 and Beyond.
8:3259-3260.
2020
-
Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report.
8:2920-2936.e1.
2020
-
Managing Food Allergy in Schools During the COVID-19 Pandemic.
8:2845-2850.
2020
-
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change.
8:2851-2857.
2020
-
Anaphylaxis as a presenting symptom of food allergy in children with no known food allergy.
8:2811-2813.e2.
2020
-
Appointment characteristics during COVID-19 restrictions: A Canadian allergy/immunology centre perspective.
8:2837-2838.
2020
-
Virtually supported home peanut introduction during COVID-19 for at-risk infants.
8:2780-2783.
2020
-
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services.
8:2125-2134.
2020
-
Comparing food allergy prevalence in vulnerable and nonvulnerable Canadians.
8:2425-2430.e11.
2020
-
Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”.
8:2450-2452.
2020
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.
8:1477-1488.e5.
2020
-
Temporal trends in prevalence of food allergy in Canada.
8:1428-1430.e5.
2020
-
When and how pediatric anaphylaxis cases reach the emergency department: Findings from the Cross-Canada Anaphylaxis Registry.
8:1406-1409.e2.
2020
-
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema.
8:901-911.
2020
-
Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma.
8:555-564.
2020
-
Eosinophilic Asthma.
8:465-473.
2020
-
Development of the Hereditary Angioedema Rapid Triage Tool.
8:310-317.e3.
2020
-
Timing of Introduction, Sensitization, and Allergy to Highly Allergenic Foods at Age 3 Years in a General-Population Canadian Cohort.
8:166-175.e10.
2020
-
Cough rhythms in asthma: Potential implication for management.
7:2024-2027.
2019
-
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
7:1793-1802.e2.
2019
-
Patient and Primary Care Physician Perceptions of Penicillin Allergy Testing and Subsequent Use of Penicillin-Containing Antibiotics: A Qualitative Study.
7:1888-1893.e1.
2019
-
Tissue compression and epinephrine deposition.
7:2096-2097.
2019
-
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study.
7:1610-1618.e4.
2019
-
To stock or not to stock? Implementation of epinephrine autoinjectors in food establishments.
7:678-680.e5.
2019
-
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma.
6:1989-1998.e3.
2018
-
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
6:1733-1741.e3.
2018
-
Errors in the Use of Inhalers by Health Care Professionals: A Systematic Review.
6:987-995.
2018
-
Chronic Eosinophilic Pneumonia: A Diagnostic Challenge.
5:1737-1738.
2017
-
A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma.
5:1378-1387.e5.
2017
-
Epinephrine Autoinjectors: New Data, New Problems.
5:1180-1191.
2017
-
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.
5:1040-1049.e4.
2017
-
Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance.
5:649-659.e2.
2017
-
Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.
5:S1-S14.
2017
-
Food Allergen Labeling and Purchasing Habits in the United States and Canada.
5:345-351.e2.
2017
-
Primary Immune Deficiencies in the Adult: A Previously Underrecognized Common Condition.
4:1101-1107.
2016
-
Inhaled Corticosteroids for Asthma Therapy in Young Children: Does Aerosol Particle Size Matter?.
4:372-372.
2016
-
Adjusting for nonresponse bias corrects overestimates of food allergy prevalence.
3:291-293.e2.
2015
-
Prevalence and Predictors of Food Allergy in Canada: A Focus on Vulnerable Populations.
3:42-49.
2015
-
Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial.
2:553-561.
2014
-
Use of abatacept in eosinophilic asthma.
2:220-221.
2014
-
Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema.
1:468-473.e4.
2013
-
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma
2021
-
Prenatal egg consumption and infant sensitization and allergy to egg, peanut, and cow's milk in the CHILD Cohort
2021
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)